164 related articles for article (PubMed ID: 31531762)
21. Tartrate-resistant acid phosphatase 5a and 5b contain distinct sugar moieties.
Kawaguchi T; Nakano T; Sasagawa K; Ohashi T; Miura T; Komoda T
Clin Biochem; 2008 Oct; 41(14-15):1245-9. PubMed ID: 18703035
[TBL] [Abstract][Full Text] [Related]
22. Tartrate-resistant acid phosphatase isoform 5a as an inflammation marker in end-stage renal disease.
Janckila AJ; Lederer ED; Price BA; Yam LT
Clin Nephrol; 2009 Apr; 71(4):387-96. PubMed ID: 19356371
[TBL] [Abstract][Full Text] [Related]
23. Age-related differences in hormonal and nutritional impact on lean anorexia nervosa bone turnover uncoupling.
Galusca B; Bossu C; Germain N; Kadem M; Frere D; Lafage-Proust MH; Lang F; Estour B
Osteoporos Int; 2006; 17(6):888-96. PubMed ID: 16541206
[TBL] [Abstract][Full Text] [Related]
24. Disease-specific expression of tartrate-resistant acid phosphatase isoforms.
Janckila AJ; Nakasato YR; Neustadt DH; Yam LT
J Bone Miner Res; 2003 Oct; 18(10):1916-9. PubMed ID: 14584907
[TBL] [Abstract][Full Text] [Related]
25. Secreted tartrate-resistant acid phosphatase 5b is a Marker of osteoclast number in human osteoclast cultures and the rat ovariectomy model.
Rissanen JP; Suominen MI; Peng Z; Halleen JM
Calcif Tissue Int; 2008 Feb; 82(2):108-15. PubMed ID: 18084692
[TBL] [Abstract][Full Text] [Related]
26. Consumption of vitamin D-and calcium-fortified soft white cheese lowers the biochemical marker of bone resorption TRAP 5b in postmenopausal women at moderate risk of osteoporosis fracture.
Bonjour JP; Benoit V; Rousseau B; Souberbielle JC
J Nutr; 2012 Apr; 142(4):698-703. PubMed ID: 22357739
[TBL] [Abstract][Full Text] [Related]
27. Acid phosphatases as markers of bone metabolism.
Igarashi Y; Lee MY; Matsuzaki S
J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Dec; 781(1-2):345-58. PubMed ID: 12450668
[TBL] [Abstract][Full Text] [Related]
28. Correlations between bone turnover markers, serum magnesium and bone mass density in postmenopausal osteoporosis.
Mederle OA; Balas M; Ioanoviciu SD; Gurban CV; Tudor A; Borza C
Clin Interv Aging; 2018; 13():1383-1389. PubMed ID: 30122910
[TBL] [Abstract][Full Text] [Related]
29. Bone mineral density and serum biochemical predictors of bone loss in patients with CKD on dialysis.
Malluche HH; Davenport DL; Cantor T; Monier-Faugere MC
Clin J Am Soc Nephrol; 2014 Jul; 9(7):1254-62. PubMed ID: 24948144
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of the activity of tartrate-resistant acid phosphatase isoform 5b in normal Chinese children--a novel marker for bone growth.
Chen CJ; Chao TY; Janckila AJ; Cheng SN; Ku CH; Chu DM
J Pediatr Endocrinol Metab; 2005 Jan; 18(1):55-62. PubMed ID: 15679069
[TBL] [Abstract][Full Text] [Related]
31. Modeling and simulation of bone mineral density in Japanese osteoporosis patients treated with zoledronic acid using tartrate-resistant acid phosphatase 5b, a bone resorption marker.
Mori Y; Kasai H; Ose A; Serada M; Ishiguro M; Shiraki M; Tanigawara Y
Osteoporos Int; 2018 May; 29(5):1155-1163. PubMed ID: 29423715
[TBL] [Abstract][Full Text] [Related]
32. Serum tartrate-resistant acid phosphatase isoforms in rheumatoid arthritis.
Janckila AJ; Neustadt DH; Nakasato YR; Halleen JM; Hentunen T; Yam LT
Clin Chim Acta; 2002 Jun; 320(1-2):49-58. PubMed ID: 11983200
[TBL] [Abstract][Full Text] [Related]
33. Serum levels of tartrate-resistant acid phosphatase-5b in breast cancer patients treated with pamidronate.
Martinetti A; Seregni E; Ripamonti C; Ferrari L; De Conno F; Miceli R; Pallotti F; Coliva A; Biancolini D; Bombardieri E
Int J Biol Markers; 2002; 17(4):253-8. PubMed ID: 12521129
[TBL] [Abstract][Full Text] [Related]
34. Tartrate-resistant acid phosphatase (TRAP) as a serum marker for bone resorption in breast cancer patients with bone metastases.
Tauchert S; di Liberto A; Cordes T; Thill M; Salehin D; Friedrich M
Clin Exp Obstet Gynecol; 2009; 36(4):219-25. PubMed ID: 20101852
[TBL] [Abstract][Full Text] [Related]
35. Comparison of bone scintigraphy with bone markers in the diagnosis of bone metastasis in lung carcinoma patients.
Ebert W; Muley T; Herb KP; Schmidt-Gayk H
Anticancer Res; 2004; 24(5B):3193-201. PubMed ID: 15510610
[TBL] [Abstract][Full Text] [Related]
36. Alternative immunoassay for tartrate-resistant acid phosphatase isoform 5b using the fluorogenic substrate naphthol ASBI-phosphate and heparin.
Janckila AJ; Simons RM; Yam LT
Clin Chim Acta; 2004 Sep; 347(1-2):157-67. PubMed ID: 15313154
[TBL] [Abstract][Full Text] [Related]
37. Utility of serum tartrate-resistant acid phosphatase isoform 5b, bone alkaline phosphatase and osteocalcin in osteoporotic fractures in Chinese patients.
Cao Y; Liu X; Xu H
Clin Lab; 2012; 58(7-8):845-50. PubMed ID: 22997989
[TBL] [Abstract][Full Text] [Related]
38. Tartrate-resistant acid phosphatase 5b is a potential biomarker for rheumatoid arthritis: a pilot study in Han Chinese.
Cheng T; Wang M; Chen Z; Eisenberg RA; Zhang Y; Zou Y; Deng Y; Wang M; Zhou L
Chin Med J (Engl); 2014; 127(16):2894-9. PubMed ID: 25131223
[TBL] [Abstract][Full Text] [Related]
39. Increased Bone Mineral Content During Rapid Weight Gain Therapy in Anorexia Nervosa.
Tubić B; Pettersson C; Svedlund A; Forslund HB; Magnusson P; Swolin-Eide D
Horm Metab Res; 2016 Sep; 48(10):664-672. PubMed ID: 27579526
[TBL] [Abstract][Full Text] [Related]
40. The association of bone metabolism with bone mineral density, serum sex hormone concentrations, and regular exercise in middle-aged men.
Remes T; Väisänen SB; Mahonen A; Huuskonen J; Kröger H; Jurvelin JS; Penttilä IM; Rauramaa R
Bone; 2004 Aug; 35(2):439-47. PubMed ID: 15268895
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
